The occurrence of invasive orbital aspergillosis in an immunocompetent individual is rare. To our knowledge, primarily bilateral invasive orbital aspergillosis has not been reported in the English literature. We are reporting this case of primary bilateral invasive orbital aspergillosis, which posed a great dilemma regarding its ideal management, to initiate a discussion and get a feedback regarding the ideal management protocol in such a situation.
The spectrum of orbital aspergillosis: A clinicopathological review. Surv Ophthalmol 1996;41:142-54.
Sino-orbital and cerebral aspergillosis: Cure with medical therapy. Mykosen 1987;30:379-85.
Aspergillosis of the orbit. Arch Ophthalmol 1969;82:302-13.
Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery. JAMA 1980; 244:814-15.
Amphotericin B refractory aspergillosis after itraconazole: Evidence for significant antagonism. Mycoses 1993;36:421-24.
In vitro susceptibility and synergy studies of aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992;15:21-34.
Aspergillus species. In: Mandell GL, Bennett JE, Dolin R (Eds). Principles and practice of infectious diseases. (5th ed). Philadelphia: Churchill Livingstone 2000;2:2674-85.
Orbital aspergillosis a fatal masquerader. J Neuroophthalmol 1997;17:257-61.
Itraconazole in the treatment of orbital aspergillosis. Ophthalmology 1996;103: 1467-70.
Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole. Ann Otol Rhinol Laryngol 1999;108:205-07.
